Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Ohsfeldt

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
Challenges in evaluating the cost-effectiveness of statinsRobert L Ohsfeldt
Archives of Internal Medicine|March 16, 2005
Common adverse effects of short-term hormone therapyRobert L Ohsfeldt
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Estimating the cost effectiveness of alternative drug treatments for postmenopausal osteoporosisRobert L Ohsfeldt
AIDS & Public Policy Journal|January 1, 1989
Societal attitudes toward AIDS and AIDS-related health insurance regulationsRobert L Ohsfeldt, Stephan Gohmann
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapyC Daniel Mullins, Robert L Ohsfeldt
Contemporary Economic Policy|April 1, 1994
Do parental involvement laws reduce adolescent abortion rates?Robert L Ohsfeldt, Stephan F Gohmann
Health Services Research|December 11, 2012
Squeezing the balloon: propensity scores and unmeasured covariate balanceJohn M Brooks, Robert L Ohsfeldt
Journal of Health and Human Services Administration|February 2, 2008
The impact of having a young child with disabilities on maternal labor supply by race and marital statusGeorge L Wehby, Robert L Ohsfeldt
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacyFadia T Shaya, Robert L Ohsfeldt
Public Choice|July 1, 1992
The economics of AIDS-related health insurance regulations: interest group influence and ideologyRobert L Ohsfeldt, Stephan F Gohmann
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
Challenges in evaluating the cost-effectiveness of statinsRobert L Ohsfeldt
Archives of Internal Medicine|March 16, 2005
Common adverse effects of short-term hormone therapyRobert L Ohsfeldt
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Estimating the cost effectiveness of alternative drug treatments for postmenopausal osteoporosisRobert L Ohsfeldt
AIDS & Public Policy Journal|January 1, 1989
Societal attitudes toward AIDS and AIDS-related health insurance regulationsRobert L Ohsfeldt, Stephan Gohmann
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapyC Daniel Mullins, Robert L Ohsfeldt
Contemporary Economic Policy|April 1, 1994
Do parental involvement laws reduce adolescent abortion rates?Robert L Ohsfeldt, Stephan F Gohmann
Health Services Research|December 11, 2012
Squeezing the balloon: propensity scores and unmeasured covariate balanceJohn M Brooks, Robert L Ohsfeldt
Journal of Health and Human Services Administration|February 2, 2008
The impact of having a young child with disabilities on maternal labor supply by race and marital statusGeorge L Wehby, Robert L Ohsfeldt
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacyFadia T Shaya, Robert L Ohsfeldt
Public Choice|July 1, 1992
The economics of AIDS-related health insurance regulations: interest group influence and ideologyRobert L Ohsfeldt, Stephan F Gohmann
Pageof 10